Pill Connect, a Manchester-based medtech company, has secured funding to enhance its medication adherence technology, vital for improving clinical trial efficiency and patient outcomes.

Target Information

Pill Connect, a Manchester-based medtech company, has developed a sophisticated digital device designed to monitor patient medication adherence. This innovative device attaches to standard pill bottles, providing pharmaceutical companies with crucial real-time data regarding dispensing patterns, including the timing and quantity of pills dispensed. Such data is invaluable for evaluating drug efficacy during clinical trials.

Despite the capabilities of Pill Connect's technology, it’s estimated that 50% of patients enrolled in clinical trials do not adhere to medication guidelines, which can significantly delay regulatory approval and lead to substantial revenue losses—estimated at $800,000 per day for each trial day delay. The company has established itself as a recognized supplier to a leading global contract research organization (CRO) and has formed partnerships with notable firms specializing in drug dispensing technologies and adherence.

Industry Overview

The life sciences sector in the UK, particularly in the North West, has experienced significant growth due to technological advancements and an increasing focus on healthcare innovation. The integration of digital health solutions, like Pill Connect's device, is e